Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy.
Microglia Ontology and Signaling.
Phosphorylated TandeMBP: A unique protein substrate for protein phosphatase assay.
Clinical, electrophysiological, and biochemical markers of peripheral and central nervous system disease in canine globoid cell leukodystrophy (Krabbe's disease).
Activation of the astrocytic Nrf2/ARE system ameliorates the formation of demyelinating lesions in a multiple sclerosis animal model.
Women's experiences of menopause in an online MS cohort: A case series.
Efficacity of exercise training on multiple sclerosis patients with cognitive impairments.
A decade of natalizumab and PML: Has there been a tacit transfer of risk acceptance?
Targeting "bad" B cells in multiple sclerosis: Could laquinimod be part of the armamentarium?
Adverse Structural and Functional Effects of Marijuana on the Brain: Evidence Reviewed.
Efficacy and safety of two different tolvaptan doses in the treatment of hyponatremia in the Emergency Department.
Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI.
Microbiomic and Posttranslational Modifications as Preludes to Autoimmune Diseases.
Nanocarriers as Tools in Delivering Active Compounds for Immune System Related Pathologies.
Neuropathic pruritus as the p]resenting symptom of lupus transverse myelitis.
Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study.
Modeling the Chronic Loss of Optic Nerve Axons and the Effects on the Retinal Nerve Fiber Layer Structure in Primary Disorder of Myelin.
Fatigue and gait speed in multiple sclerosis: Assessment and relationship.
Evaluation of the benefits of treatment with TENS for neurological lower urinary tract dysfunctions.
Corrigendum.
Cognitive Impairment in Multiple Sclerosis.
The impact of adjusted work conditions and disease-modifying drugs on work ability in multiple sclerosis.
Gait Profile Score in multiple sclerosis patients with low disability.
[Symptoms of obsessive-compulsive disorder in neurological diseases].
Patient-reported adverse effects of high-dose intravenous methylprednisolone treatment: a prospective web-based multi-center study in multiple sclerosis patients with a relapse.
Pages
« first
‹ previous
…
824
825
826
827
828
829
830
831
832
…
next ›
last »